DNLI
Denali Therapeutics Inc
20.40$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | |
| – | – | – | 110.9% | 724.9% | 63.3% | 11.5% | 6.5% | 5.1% | – | – | |
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | |
| – | – | – | 110.9% | 724.9% | 63.3% | 545.3% | 330.7% | 128.2% | – | – | |
| – | – | – | 25.0% | 174.2% | 18.0% | 162.5% | 83.4% | 31.3% | – | – | |
| – | – | – | 135.9% | 899.1% | 81.3% | 707.8% | 414.2% | 159.5% | – | – | |
| – | – | – | -35.9% | -799.1% | 18.7% | -607.8% | -314.2% | -59.5% | – | – | |
| – | – | – | 1.5% | 57.0% | 5.3% | 27.1% | 13.6% | – | – | – | |
| – | – | – | -28.1% | -742.1% | 21.4% | -598.3% | -300.5% | -43.9% | – | – | |
| – | – | – | 7.8% | -1.3% | 0.2% | -1.2% | 0.0% | 0.0% | – | – | |
| – | – | – | -28.1% | -740.7% | 21.2% | -597.2% | -300.6% | -43.9% | – | – | |
| – | – | – | -30.2% | -769.1% | 21.2% | -590.1% | -291.0% | -38.9% | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.